{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:12:51Z","timestamp":1792066371164,"version":"4.4.0"},"reference-count":14,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303738"],"award-info":[{"award-number":["82303738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403976"],"award-info":[{"award-number":["82403976"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473036"],"award-info":[{"award-number":["82473036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Breast cancer brain metastasis (BCBrM) remains one of the most lethal manifestations of breast cancer. Its response to immunotherapy is severely limited by the blood-brain barrier, which restricts immune cell infiltration and antigen presentation, thereby creating an immunosuppressive microenvironment. To overcome these barriers, recent studies have focused on novel immune checkpoints, including the Lymphocyte-Activated Gene 3\u2013Galectin 3 (LAG3\u2013LGALS3) and T-Cell Immunoreceptor with Ig and ITIM Domains\u2013Nectin Cell Adhesion Molecule 2 (TIGIT\u2013NECTIN2) axes, as well as on the reprogrammed metastatic ecosystem driven by immunosuppressive cells such as Forkhead Box P3-positive (FOXP3\u207a) Regulatory T (Treg) cells, Lysosomal-Associated Membrane Protein 3-positive (LAMP3\u207a) tolerogenic dendritic cells (DCs), C-C Motif Chemokine Ligand 18-positive (CCL18\u207a) M2-like macrophages, Regulator of G-Protein Signaling 5-positive (RGS5\u207a) cancer-associated fibroblasts (CAFs), Galectin 1-positive (LGALS1\u207a) and TANK-Binding Kinase 1-positive (TBK1\u207a) microglia, and phosphorylated Signal Transducer and Activator of Transcription 3-positive (pSTAT3\u207a) reactive astrocytes. In addition, targeted inhibition of tumor-derived N-acetyltransferase 8-like (NAT8L) and metabolites N-Acetylaspartate (NAA), suppression of the N-Methyl-D-Aspartate Receptor (NMDAR) signaling pathway in tumor cells, and interventions against \u03b3-Aminobutyric Acid (GABA)ergic reprogramming in BCBrM cells. Moreover, targeted interventions against distinct immune escape pathways\u2014such as the Ubiquitin-Conjugating Enzyme E2T (UBE2T)\/Cell Division Cycle 42 (CDC42)\/Cluster of Differentiation 276 (CD276) and C-C Motif Chemokine Ligand 2\u2013C-C Motif Chemokine Receptor 2\/C-C Motif Chemokine Receptor 4 (CCL2\u2013CCR2\/CCR4) axes\u2014have shown promise in reshaping the immune microenvironment and enhancing the efficacy of conventional immunotherapy. Collectively, this perspective outlines evolving strategies in immune checkpoint modulation, cellular ecosystem reprogramming, and neuroimmune intervention, providing a forward-looking framework to enhance the efficacy of immunotherapy in BCBrM.<\/jats:p>","DOI":"10.1136\/jitc-2025-014134","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:25:14Z","timestamp":1775147114000},"page":"e014134","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting the neuro-immune crosstalk in breast cancer brain metastases"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5205-9923","authenticated-orcid":false,"given":"Yutian","family":"Zou","sequence":"first","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadi","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Guangzhou Institute of Cancer Research, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Yuan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-782X","authenticated-orcid":false,"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2026040209250794000_14.4.e014134.1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/neuonc\/noae219","article-title":"The immune landscape in brain metastasis","volume":"27","author":"Schreurs","year":"2025","journal-title":"Neuro Oncol"},{"key":"2026040209250794000_14.4.e014134.2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43556-025-00251-0","article-title":"Cancer brain metastasis: molecular mechanisms and therapeutic strategies","volume":"6","author":"Lu","year":"2025","journal-title":"Mol Biomed"},{"key":"2026040209250794000_14.4.e014134.3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ccell.2025.03.025","article-title":"Pan-cancer human brain metastases atlas at single-cell resolution","volume":"43","author":"Xing","year":"2025","journal-title":"Cancer Cell"},{"key":"2026040209250794000_14.4.e014134.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-023-01273-y"},{"key":"2026040209250794000_14.4.e014134.5","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203699","article-title":"The Single\u2010Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer","volume":"10","author":"Zou","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026040209250794000_14.4.e014134.6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ccell.2024.05.006","article-title":"Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell"},{"key":"2026040209250794000_14.4.e014134.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1576-6"},{"key":"2026040209250794000_14.4.e014134.8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1322098111"},{"key":"2026040209250794000_14.4.e014134.9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012009","article-title":"Exploring the tumor microenvironment in diffuse intrinsic pontine glioma: immunological insights and therapeutic challenges","volume":"13","author":"Van den Ende","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026040209250794000_14.4.e014134.10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012457","article-title":"Why has immune \u201ccheckpoint\u201d therapy failed in most clinical trials?","volume":"13","author":"Yang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026040209250794000_14.4.e014134.11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010782","article-title":"UBE2T\/CDC42\/CD276 signaling axis mediates brain metastasis of triple-negative breast cancer via lysosomal autophagy","volume":"13","author":"Shi","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026040209250794000_14.4.e014134.12","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/brain\/awae347","article-title":"CCL2 blockade combined with PD-1\/P-selectin immunomodulators impedes breast cancer brain metastasis","volume":"148","author":"Israeli Dangoor","year":"2025","journal-title":"Brain (Bacau)"},{"key":"2026040209250794000_14.4.e014134.13","doi-asserted-by":"crossref","unstructured":"Khan F , Petrosyan E , Liu Y , et al . Microglial TBK1 Signaling Promotes Breast Cancer Brain Metastasis. Cancer Res 2025;18. doi:10.1158\/0008-5472.c.8227049","DOI":"10.1158\/0008-5472.c.8227049"},{"key":"2026040209250794000_14.4.e014134.14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1158\/2159-8290.CD-24-0134","article-title":"TIMP1 Mediates Astrocyte-Dependent Local Immunosuppression in Brain Metastasis Acting on Infiltrating CD8+ T Cells","volume":"15","author":"Priego","year":"2025","journal-title":"Cancer Discov"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-014134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:25:16Z","timestamp":1775147116000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-014134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,2]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/jitc-2025-014134"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-014134","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}